Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recovery × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 12989 Neoplasms 10382 Carcinoma, Non-Small-Cell Lung 6793 Prostatic Neoplasms 6196 Colorectal Neoplasms 5862 Lung Neoplasms 5040 Multiple Myeloma 3541 Pancreatic Neoplasms 3511 Neoplasm Metastasis 3478 Leukemia, Myeloid, Acute 3467 Carcinoma, Hepatocellular 3227 Ovarian Neoplasms 3138 Melanoma 3120 Stomach Neoplasms 3019 Lymphoma 2970 Head and Neck Neoplasms 2575 Recurrence 2527 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2485 Leukemia 2353 Colonic Neoplasms 2317 Brain Neoplasms 2293 Lymphoma, Non-Hodgkin 2257 Rectal Neoplasms 2171 Uterine Cervical Neoplasms 2164 Glioblastoma 1993 Leukemia, Lymphocytic, Chronic, B-Cell 1985 Carcinoma, Renal Cell 1897 Squamous Cell Carcinoma of Head and Neck 1856 Lymphoma, Follicular 1829 Esophageal Neoplasms 1786

Interventions

Propofol 1 Powders 1 Injections, Intravenous 1 Flumazenil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05435911 2023-01-13

Comparison of Recovery From General Anesthesia in Remimazolam With Flumazenil vs. Propofol

Seoul National University Hospital

Phase NA Completed

Recovery

Data powered by HemOnc (CC BY 4.0) Colophon ⚡